These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33837046)

  • 1. WHO's allocation framework for COVAX: is it fair?
    Sharma S; Kawa N; Gomber A
    J Med Ethics; 2022 Jul; 48(7):434-438. PubMed ID: 33837046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews.
    Gorodensky A; Grundy Q; Persaud N; Kohler JC
    J Glob Health; 2023 Dec; 13():04165. PubMed ID: 38063440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing global COVID-19 vaccine allocation: An agent-based computational model of 148 countries.
    Li Q; Huang Y
    PLoS Comput Biol; 2022 Sep; 18(9):e1010463. PubMed ID: 36067157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX.
    Fajber K
    Health Hum Rights; 2022 Dec; 24(2):219-228. PubMed ID: 36579321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal spatial evaluation of a pro rata vaccine distribution rule for COVID-19.
    Castonguay FM; Blackwood JC; Howerton E; Shea K; Sims C; Sanchirico JN
    Sci Rep; 2023 Feb; 13(1):2194. PubMed ID: 36750592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
    Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
    Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism design for a fair and equitable approach to global vaccine distribution: The case of COVID-19.
    Abedrabboh K; Al-Majid L; Al-Fagih Z; Al-Fagih L
    PLOS Glob Public Health; 2023; 3(12):e0001711. PubMed ID: 38153908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020-2021.
    Hasan Q; Elfakki E; Fahmy K; Mere O; Ghoniem A; Langar H; Musa N; Attia R; Othman MM; Samhouri D; Chaudhri I; Abubakar A; Hajjeh R; Hutin YJ
    BMJ Glob Health; 2022 Jun; 7(Suppl 4):. PubMed ID: 35764354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
    Geiger S; McMahon A
    J Med Ethics; 2023 Aug; 49(8):583-590. PubMed ID: 34848492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Inefficient and Unjust Global Distribution of COVID-19 Vaccines: From a Perspective of Critical Global Justice.
    Li Z; Lu J; Lv J
    Inquiry; 2021; 58():469580211060992. PubMed ID: 34865544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why does the COVAX facility fail to bridge the 'immunization gap'?
    Shao Q
    J Public Health Policy; 2024 Mar; 45(1):126-136. PubMed ID: 38243069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines.
    Voit K; Timmermann C; Orzechowski M; Steger F
    Front Public Health; 2023; 11():995683. PubMed ID: 36778578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
    Bai AY; Zhang B; Jiang Y; Qiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.